Expression of heterogeneous nuclear ribonucleoprotein A2/B1 in bronchial epithelium of chronic smokers

Clinical Cancer Research

Volumn 4, Issue 7, 1998, Pages 1631-1640

  Zhou, Jun ^a   Mulshine, James L ^a   Ro, Jae Y ^b   Avis, Ingalill ^a   Yu, Ren ^b   Lee, J Jack ^b   Morice, Rodolfo ^b   Lippman, Scott M ^b   Lee, Jin S ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; ISOTRETINOIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 703D4; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; BRONCHUS MUCOSA; CANCER CELL CULTURE; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG BIOPSY; LUNG CANCER; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOKING; SQUAMOUS CELL METAPLASIA;

BIOPSY; BRONCHI; CARCINOMA, SMALL CELL; DNA-BINDING PROTEINS; EPITHELIUM; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B; HUMANS; LUNG NEOPLASMS; SMOKING; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0031776111     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Parker, S. L., Tong, T., Bolden, S., and Wingo, P. A. Cancer Statistics. CA Cancer J. Clin., 47: 5-27, 1997.
2. Saccomanno, G., Saunders, R. P., and Klein, M. G. Cytology of the lung in reference to irritant, individual sensitivity and healing. Acta Cytol., 14: 377-381, 1970.
3. Frost, J. K., Fontana, R. S., and Melamed, M. R. Early lung cancer detection: summary and conclusions. Am. Rev. Respir. Dis., 130: 565-570, 1984.
4. Tockman, M. S., Gupta, P. K., Myers, J. D., Frost, J. K., Baylin, S. B., Gold, E. B., Chase, A. M., Wilkinson, P. H., and Mulshine, J. L. Sensitive and specific monoclonal antibody recognition of human lung cancer antigen on preserved sputum cells: a new approach to early lung cancer detection. J. Clin. Oncol., 6: 1685-1693, 1988.
5. Mulshine, J. L., Cuttitta, F., Bibro, M., Fedorko, J., Fargion, S., Little, C., Carney, D. N., Gazdar, A. F., and Minna, J. D. Monoclonal antibodies that distinguish non-small cell from small cell lung cancer. J. Immunol., 131: 497-502, 1983.
6. Zhou, J., Mulshine, J. L., Unsworth, E. J., Scott, F. M., Avis, I. M., Vos, M. D., and Treston, A. M. Purification and characterization of a protein that permits early detection of lung cancer. J. Biol. Chem., 271: 10760-10766, 1996.
7. Tockman, M. S., Mulshine, J. L., Piantadosi, S., Erozan, Y. S., Gupta, P. K., Ruckdeschel, J. C., Taylor, P. R., Zhukov, T., Zhou, W. H., Qiao, Y. L., Yao, S. X., Lung Cancer Early Detection Working Group Investigators, and Yunan Tin Company Investigators. Prospective detection of preclinical lung cancer: results from two studies of hnRNP overexpression. Clin. Cancer Res., 3: 2237-2246, 1997.
8. Slaughter, D. P., Southwick, H. W., and Smejkal, W. "Field cancerization" in oral stratified squamous epithelium. Cancer (Phila.), 6: 963-968, 1953.
9. Auerbach, O., Stout, A. P., Hammond, C., and Garfinkel, M. A. Changes in bronchial epithelium in relation to cigarette smoking and in relation to lung cancer. N. Engl. J. Med., 265: 253-267, 1961.
10. Saccomanno, G., Archer, V. E., and Auerbach, O. Development of carcinoma of the lung as reflected in exfoliated cells. Cancer (Phila.), 33: 256-270, 1974.
11. Lee, J. S., Lippman, S., Benner, S., Lee, J., Ro, J., Lukeman, J., Morice, R., Peter, E., Pang, A., Fritsche, H., and Hong, W. Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia. J. Clin. Oncol., 12: 937-945, 1994.
12. Lippman, S. M., Heyman, R. A., Kurie, J. M., Benner, S. E., and Hong, W. K. Retinoids and chemoprevention: clinical and basic studies. J. Cell Biochem. Suppl., 22: 1-10, 1995.
13. Rubin, M., Fenig, E., Rosenauer, A., Menendez-Botet, C., Achkar, C., Bentel, J., Yahalom, J., Mendelsohn, J., and Miller, W. J. 9-cis Retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein. Cancer Res., 54: 6549-6556, 1994.
14. Halliday, G., Ho, K., and Barnetson, R. Regulation of the skin immune system by retinoids during carcinogenesis. J. Invest. Dermatol., 99: 83S-86S, 1992.
15. Chomienne, C., Ballerini, P., Huang, M., Comic, M., Abita, J., Castaigne, S., and Degos, L. In vitro effects of retinoic acid. Nouv. Rev. Fr. Hematol., 32: 32-34, 1990.
16. Lotan, R. Retinoids in cancer chemoprevention. FASEB J., 10: 1031-1039, 1996.
17. An, G., and Wu, R. cDNA cloning of a hnRNP A1 isoform and its regulation by retinol in monkey tracheobronchial epithelial cells. Biochem. Biophys. Acta, 1172: 292-300, 1993.
18. Avis, I., Mathias, A., Unsworth, E., Miller, M., Cuttitta, F., Mulshine, J., and Jakowlew, S. Analysis of small cell lung cancer cell growth inhibition by 13-cis-retinoic acid: importance of bioavailability. Cell Growth Differ., 6: 485-492, 1995.
19. Jensen, S. M., Steinberg, S., Jones, J., and Linnoila, R. I. Clara eell 10 KD protein mRNA in normal and atypical regions of human respiratory epithelium. Int. J. Cancer, 58: 629-637, 1994.
20. Nasiell, M. The general appearance of the bronchial epithelium in bronchial carcinoma. Acta Cytol., 7: 97-106, 1963.
21. Nettesheim, P., and Szakal, M. S. Morphogenesis of alveolar bronchiolization. Lab. Invest., 26: 210-219, 1972.
22. Zhou, J., Jensen, S. M., Steinberg, S. M., Mulshine, J. L., and Linnoila, I. Expression of early lung cancer detection marker p31 in neoplastic and non-neoplastic respiratory epithelium. Lung Cancer, 14: 85-97, 1996.
23. Linnoila, R. I., Mulshine, J. L., Steinberg, S. M., Funa, K., Matthews, M. J., Cotelingam, J. D., and Gazdar, A. F. Neuroendocrine differentiation in endocrine and nonendocrine lung carcinoma. Am. J. Clin. Pathol., 90: 1-12, 1988.
24. Phelps, R., Johnson, B., Ihde, D., Gazdar, A., Carbone, D., McClintock, P., Linnoila, R., Matthews, M., Bunn. P. J., Carney, D., Minna, J., and Mulshine, J. NCI-Navy Medical Oncology Branch cell line data base. J. Cell. Biochem. Suppl., 24: 32-91, 1996.
25. Solomon, M. D., Greenberg, S. D., and Spjut, H. J. Morphology of bronchial epithelium adjacent to adenocarcinoma of the lung. Mod. Pathol., 3: 684-687, 1990.
26. Yakubovskaya, M. S., Spiegelman, V., Luo, F. C., Malaev, S., Salnev, A., Zborovskaya, I., Gasparyan, A., Polotsky, B., Machaladze, Z., and Trachtenberg, A. High frequency of K-ras mutations in normal appearing lung tissues and sputum of patients with lung cancer. Int. J. Cancer, 63: 810-814, 1995.
27. Hung, J., Kishimoto, Y., Sugio, K., Virmani, A., Mclntire, D. D., Minna, J., and Gazdar, A. F. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. J. Am. Med. Assoc., 273: 558-563, 1995.
28. Brambilla, E. Early detection of lung cancer. In: Y. Martinet, J. M. Vignaud, N. Martinet, F. Hirsch, and J. L. Mulshine (eds.), Clinical and Biological Basis of Lung Cancer Prevention, pp. 39-56. Basel, Switzerland: Birkhauser, 1998.
29. Sozzi, G., Miozzo, M., Donghi, R., Piolotti, S., Cariani, C. T., Pastorino, U., Dellaporta, G., and Pierotti, M. A. Deletions of 17p and p53 mutations in preneoplastic lesions of the lung. Cancer Res., 52: 6097-6082, 1992.
30. Sozzi, G., Miozzo, M., Pastorino, U., Pilotti, S., Donghi, R., Giarola, M., De Gregorio, L., Manenti, G., Radice, P., and Minoletti, F. Genetic evidence for an independent origin of multiple preneoplastic and neoplastic lung lesion. Cancer Res., 55: 135-140, 1995.
31. Scott, F. M., Modali, R., Lehman, T. A., Seddon, M., Kelly, K., Dempsey, E. C., Wilson, V., Tockman, M. S., and Mulshine, J. L. High frequency of K-ras codon 12 mutations in bronchoalveolar lavage fluid of patients at high risk for second primary lung cancer. Clin. Cancer Res., 3: 479-482, 1997.
32. Crowell, R. E., Gilliland, F. D., Temes, R. T., Harms, H. J., Neft, R. E., Heaphy, E., Auckley, D. H., Crooks, L. A., Jordan, S. W., Samet, J. M., Lechner, J. F., and Belinsky, S. A. Detection of trisomy 7 in nonmalignant bronchial epithelium from lung cancer patients and individuals at risk for lung cancer. Cancer Epidemiol. Biomark. Prev., 5: 631-637, 1996.
33. Hirsch, F. R., Brambilla, E., Gray, N., Gritz, E., Kelloff, G. J., Lonnoila, R. I., Pastorino, U., and Mulshine, J. L. Prevention and early detection of lung cancer: clinical aspects. Lung Cancer, 17: 163-174, 1997.
34. Tockman, M. S., Erozan, Y. S., Gupta, P., Piantadosi, S., Mulshine, J. L., and Ruckdeschel, J. C. The early detection of second primary lung cancers by sputum immunostaining. Chest, 106: 385S-390S, 1994.
35. McLemore, T. L., Adelberg, S., Liu, M. C., McMahon, N. A., Yu, S. J., Hubbard, W. C., Czerwinski, M., Wood, T. G., Storeng, R., and Lubet, R. A. Expression of CYP1A1 gene in patients with lung cancer: evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas. J. Natl. Cancer Inst., 82: 1333-1339, 1990.
36. Montuenga, L., Zhou, J., Avis, I., Martinez, A., Vos, M., Sunday, M., and Mulshine, J. L. Expression of heterogeneous nuclear ribonucleoprotein (hnRNP) A2/B1 changes with critical stages of mammalian lung development. J. Resp. Cell Mol. Biol., in press, 1998.
37. Hong, W., Lippman, S., Itri, L., Karp, D., Lee, J., Byers, R., Schantz, S., Kramer, A., Lotan, R., and Peters, L. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N. Engl. J. Med., 323: 825-827, 1990.
38. McLarty, J., Holiday, D., Girard, W., Yanagihara. R., Kummet, T., and Greenberg, S. β-Carotene, vitamin A, and lung cancer chemoprevention: results of an intermediate endpoint study. Am. J. Clin. Nutr., 62: 1431S-1438S, 1995.
39. Arnold, A., Browman, G., Levine, M., D'Souza, T., Johnstone, B., Skingley, P., Turner-Smith, L., Cayco. R., Booker, L., and Newhouse, M. The effect of the synthetic retinoid etretinate on sputum cytology: results from a randomized trial. Br. J. Cancer, 65: 737-743, 1992.
40. Mao, L., Fan, Y. H., Shin, D. M., Papadimitrakopoulou, V., El-Naggar, A. K., Izzo, G. J., Lee, J. S., Clayman, G., Shin, H. J., Hittleman, W. N., Lippman, S. M., and Hong, W. K. Loss of heterozygosity at 9p21 is frequent in head and neck preneoplastic lesions and independent of clinical parameters. Proc. Am. Assoc. Cancer Res., 39: 360, 1998.
41. Benner, S. E., Pajak, T. F., Lippman, S. M., and Hong, W. K. Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck: long term follow-up. J. Natl. Cancer Inst., 86: 140-141, 1994.
42. Mulshine, J. L., De Luca, L. M., and Dedrick, R. L. Regional delivery of retinoids: a new approach to early lung cancer intervention. In: Y. Martinet, J. M. Vignaud, N. Martinet, F. Hirsch, and J. L. Mulshine (eds.), Clinical and Biological Basis of Lung Cancer Prevention, pp. 273-284. Basel, Switzerland: Birkhauser, 1998.